Jae Suk Woo Selected Research

Jae Suk Woo Research Topics

Disease

4	Neoplasms (Cancer) 04/2019 - 08/2009
2	Breast Neoplasms (Breast Cancer) 05/2014 - 04/2012
2	Glioma (Gliomas) 12/2012 - 08/2009
2	Hypoxia (Hypoxemia) 11/2006 - 01/2002
2	Necrosis 11/2003 - 09/2003
2	Acute Kidney Injury (Acute Renal Failure) 11/2003 - 09/2003
1	Ovarian Neoplasms (Ovarian Cancer) 04/2019
1	Alzheimer Disease (Alzheimer's Disease) 05/2016
1	Diabetes Complications 05/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2016
1	Ischemia 11/2006

Drug/Important Bio-Agent (IBA)

3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014 - 01/2002
3	CaspasesIBA 12/2012 - 08/2009
3	AntioxidantsIBA 11/2006 - 01/2002
2	Silybin (Lagosa)IBA 05/2014 - 08/2009
2	FlavonoidsIBA 04/2012 - 08/2009
2	Cisplatin (Platino)FDA LinkGeneric 11/2003 - 09/2003
2	Hydroxyl RadicalIBA 09/2003 - 01/2002
2	Deferoxamine (Desferal)FDA LinkGeneric 09/2003 - 01/2002
2	CatalaseIBA 09/2003 - 01/2002
2	1,3-dimethylthioureaIBA 09/2003 - 01/2002
1	ResveratrolIBA 04/2019
1	PolyphenolsIBA 04/2019
1	Sildenafil Citrate (Viagra)FDA Link 05/2016
1	Advanced Glycation End ProductsIBA 05/2016
1	Adenosine A3 ReceptorIBA 12/2012
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 12/2012
1	LuteolinIBA 04/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2006
1	RTKI cpdIBA 11/2006
1	Phosphotransferases (Kinase)IBA 11/2006
1	Pentoxifylline (Trental)FDA LinkGeneric 11/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2003
1	Superoxides (Superoxide)IBA 09/2003
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 09/2003
1	Pyruvic Acid (Pyruvate)IBA 09/2003
1	ThioureaIBA 09/2003
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2003
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 09/2003
1	PhenanthrolinesIBA 01/2002
1	Superoxide Dismutase-1IBA 01/2002
1	Adenosine Triphosphate (ATP)IBA 01/2002
1	Antimycin AIBA 01/2002
1	Butylated Hydroxyanisole (BHA)IBA 01/2002
1	Chelating AgentsIBA 01/2002
1	IronIBA 01/2002
1	N,N'-diphenyl-4-phenylenediamineIBA 01/2002

Therapy/Procedure

1	Oral Administration 08/2009